CRDF
Cardiff Oncology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.86
-0.05 ▼ -2.62%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$1.86
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.69 | Insider Own | 8.95% | Shs Outstand | 0.07B | Perf Week | -1.06% |
| Market Cap | 0.13B | Forward P/E | - | EPS next Y | -31.85% | Insider Trans | - | Shs Float | 0.06B | Perf Month | 16.25% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | -0.13 | Inst Own | 33.74% | Short Float | 28.41% | Perf Quarter | -24.08% |
| Income | -0.05B | P/S | 215.53 | EPS this Y | 14.54% | Inst Trans | 3.08% | Short Ratio | 14.52 | Perf Half Y | -10.58% |
| Sales | 0.00B | P/B | 2.8 | EPS next 5Y | -17% | ROA | -57.65% | Short Interest | 17.68M | Perf YTD | -33.81% |
| Book/sh | 0.66 | P/C | 2.18 | EPS past 3/5Y | 8.24% 8.71% | ROE | -71.45% | 52W High | -59.17% ($4.55) | Perf Year | -52.91% |
| Cash/sh | 0.85 | P/FCF | - | Sales past 3/5Y | 15.39% 10.13% | ROIC | -100.85% | 52W Low | 25.68% ($1.48) | Perf 3Y | 8.77% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 28.02% | Gross Margin | -52.45% | Volatility(W/M) | 7.81% 7.18% | Perf 5Y | -82.86% |
| Dividend TTM | - | EV/Sales | 118.12 | Sales Y/Y TTM | -13.3% | Oper. Margin | -8256.32% | ATR (14) | 0.15 | Perf 10Y | -99.52% |
| Dividend Ex-Date | - | Quick Ratio | 3.67 | EPS Q/Q | 50.16% | Profit Margin | -7736.26% | RSI (14) | 46.91 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.67 | Sales Q/Q | 60.93% | SMA20 | 2.25% ($1.82) | Beta | 1.36 | Target Price | $8.36 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | -13.24% ($2.14) | Rel Volume | 0.29 | Prev Close | $1.91 |
| Employees | 31 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 41.8% 134.78% | SMA200 | -27.06% ($2.55) | Avg Volume(3M) | 1.22M | Price | $1.86 |
| IPO | 2004/7/27 | Option/Short | Yes/Yes | Trades | 1494 | Volume | 352,625 | Change | -2.62% |
뉴스 로딩 중...